This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, Hong Kong, Croatia, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa
The drug ELIDEL contains one active pharmaceutical ingredient (API):
|
1
Pimecrolimus
UNII 7KYV510875 - PIMECROLIMUS
|
|
Pimecrolimus is a lipophilic anti-inflammatory ascomycin macrolactam derivative and a cell selective inhibitor of the production and release of pro-inflammatory cytokines. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| ELIDEL Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D11AH02 | Pimecrolimus | D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AH Agents for dermatitis, excluding corticosteroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 8802G |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 541518090008017, 541518090008117, 541518090008207 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02247238 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): H6810913 |
| Country: EE | Ravimiamet | Identifier(s): 1104680, 1149511, 1149522, 1151468, 1477009 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 65029 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 056763, 187595, 371284 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 30115, 40508, 40509 |
| Country: HK | Department of Health Drug Office | Identifier(s): 51217 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4583, 4619 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1004326 |
| Country: MT | Medicines Authority | Identifier(s): MA1507/00901, PI908/23501A |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 149M2002 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 14866757 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 69566 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 10301 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100110694, 100379657, 100450584 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68696001, W68696002, W68696003, W68696004, W68696005 |
| Country: SG | Health Sciences Authority | Identifier(s): 12179P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8698856350305, 8698856350497, 8698856350503 |
| Country: US | FDA, National Drug Code | Identifier(s): 0187-5100, 0187-5101, 0187-5102, 0187-5103 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 36/34/0522 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
